← Back
Data updated: Mar 10, 2026
CARLSBAD
ImmunologyCardiovascularInfectious Disease
CARLSBAD is a generic drug manufacturer focused on Immunology, Cardiovascular, Infectious Disease. Key products include FLUOXETINE HYDROCHLORIDE.
1998
Since
8
Drugs
-
Trials
123
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ACYCLOVIR 2026-01-22
Labeling
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
DICLOFENAC SODIUM 2025-12-31
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-12-17
Labeling
DICLOFENAC SODIUM 2025-11-05
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 25%
1 drugs
Cardiovascular 25%
1 drugs
Infectious Disease 25%
1 drugs
Dermatology 25%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Infectious Disease, Dermatology, Immunology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Immunology
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Dermatology, Immunology
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
Discontinued (3)
Company Info
- First Approval
- 1998-11-13
- Latest
- 2024-11-21
- Applications
- 8